CHENG Zengyu,XU Haodong,PANG Fengtao,et al.Experience of LU Zhizheng in Treatment of Sjögren's Syndrome:from the view of Yin-Fire[J].Journal of Traditional Chinese Medicine,2022,63(06):516-520.
CHENG Zengyu,XU Haodong,PANG Fengtao,et al.Experience of LU Zhizheng in Treatment of Sjögren's Syndrome:from the view of Yin-Fire[J].Journal of Traditional Chinese Medicine,2022,63(06):516-520.DOI: 10.13288/j.11-2166/r.2022.06.004.
Experience of LU Zhizheng in Treatment of Sjögren's Syndrome:from the view of Yin-Fire
This paper summarized the experience of traditional Chinese medicine (TCM) master LU Zhizheng in treating Sjögren's syndrome (SS) from the view of
yin
-fire. SS belongs to the category of dryness
bi
(痹) in TCM. Master LU believes that the
yin
-fire described in LI Dongyuan's
Treatise on the Spleen and Stomach
(《脾胃论》) is similar with dryness
bi
in the pathogenesis and symptoms. Both of them stem from the insufficiency of the spleen-kidney, and internal retention of blood stasis, and have the characteristic of “exuberant fire transforming into dryness, injuring
yin
and accumulating toxin”. The four factors including deficiency, dryness, stasis, and toxin influence each other, which are mutual causes and effects, and eventually lead to the pattern of deficiency-excess complex. Learning from method of treating
yin
-fire in
Treatise on the Spleen and Stomach
(《脾胃论》), and considering the characteristics of dryness
bi
, master LU suggests “maintaining the middle and fortifying the spleen, protecting the kidney essence, enriching
yin
and nourishing blood, promoting fluid production and moistening dryness, moving
qi
and and unblocking the collaterals, resolving stasis and toxins” based on syndrome differentiation when treating dryness
MARIETTE X , CRISWELL LA . Primary Sjögren's Syndrome [J]. N Engl J Med , 2018 , 378 ( 10 ): 931 - 939 .
GOTTENBERG JE , RAVAUD P , PUÉCHAL X , et al . Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER rando-mized clinical trial [J]. JAMA , 2014 , 312 ( 3 ): 249 - 258 .
DÖRNER T , POSCH MG , LI Y , et al . Treatment of primary Sjogren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor bl ockade coupled with enhanced, antibody-dependent cellular cytotoxicity [J]. Ann Rheum Dis , 2019 , 78 ( 5 ): 641 - 647 .
BAER AN , GOTTENBERG JE , CLAIR EWST , et al . Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase Ⅲ, randomised, placebo-controlled trial [J]. Ann Rheum Dis , 2020 , 80 ( 3 ): 339 - 348 .
FELTEN R , DEVAUCHELLE-PENSEC V , SEROR R , et al . Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial [J]. Ann Rheum Dis , 2020 . doi: 10.1136/annrheumdis-2020-218467 http://dx.doi.org/10.1136/annrheumdis-2020-218467 .
FANG Dingya's Experience in Staged Treatment of Sjögren's Syndrome based on Dryness Toxin Theory
Discussion on the Pathogenesis and Treatment of Sjögren's Syndrome Based on YE Gui's Theory of “Upper Dryness Treats Qi and Lower Dryness Treats Blood”
Professor LU Zhizheng′s Experience for Treatment of Hypertension through Spleen-Kidney Regulation Theory
Clinical Experience of Professor CUI Yinglin in Treating Pediatric Mitochondrial Encephalomyopathy Based on the Original Qi Theory
YANG Zhen's Interpretation of the Wumei Pill (乌梅丸) Based on the Theory of Qi Dynamics of Ministerial Fire
Related Author
ZHANG Haoyu
HAN Shuhua
DONG Fei
DU Liyan
WANG Xin
ZHOU Caiyun
TANG Jinyang
HE Jiale
Related Institution
Xiyuan Hospital,China Academy of Chinese Medical Sciences
Graduate School,China Academy of Chinese Medical Sciences
Guang 'anmen Hospital,China Academy of Chinese Medical Sciences
Eye Hospital, China Academy of Chinese Medical Sciences
Guang′anmen Hospital, China Academy of Chinese Medical Sciences